The vibriosis treatment products market is projected to grow from USD 1,245.4 million in 2026 to USD 2,764.4 million by 2036, at a CAGR of 8.3%. Antibiotics will dominate with a 44.0% market share, while marine fish will lead the applications segment with a 62.0% share.